CLINICAL GENOTYPING AND EFFICACY OUTCOMES: EXPLORATORY BIOMARKER DATA FROM THE PHASE II ABIGAIL STUDY OF 1ST-LINE BEVACIZUMAB plus CHEMOTHERAPY IN NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NS-NSCLC)

Resource

Ann. Oncol., 23, 406-406

Journal

Ann. Oncol.

Journal Issue

23

Pages

406-406

Date Issued

2012

Date

2012

Author(s)

Pallaud, C.

Reck, M.

Juhasz, E.

Szima, B.

Yu, C.

Burdaeva, O.

Orlov, S.

Scherer, S. J.

Archer, V.

Mok, T. S. K.

URI

http://ntur.lib.ntu.edu.tw//handle/246246/259156

SDGs

[SDGs]SDG3

File(s)

Name

index.html

Size

23.1 KB

Format

HTML

Checksum

(MD5):3ec0b6be1835cf1a315e07de8dd4e890